Home/Filings/4/0001225208-11-010884
4//SEC Filing

Stern Lawrence D 4

Accession 0001225208-11-010884

CIK 0001405197other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 3:15 PM ET

Size

5.5 KB

Accession

0001225208-11-010884

Insider Transaction Report

Form 4
Period: 2011-03-31
Stern Lawrence D
DirectorChairman & CEO
Transactions
  • Tax Payment

    Common Stock

    2011-03-31$26.80/sh82,067$2,199,396149,899 total
Holdings
  • Common Stock

    (indirect: By Trust)
    970,136
Footnotes (1)
  • [F1]Includes restricted share units representing the right to receive 45,366 shares of the Issuer's common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting person, dated as of September 30, 2009.

Documents

1 file

Issuer

Talecris Biotherapeutics Holdings Corp.

CIK 0001405197

Entity typeother

Related Parties

1
  • filerCIK 0001472128

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 3:15 PM ET
Size
5.5 KB